Shielding of the A1 domain by the D′D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V

被引:105
|
作者
Ulrichts, H
Udvardy, MS
Lenting, PJ
Pareyn, I
Vandeputte, N
Vanhoorelbeke, K
Deckmyn, H
机构
[1] Katholieke Univ Leuven, Lab Thrombosis Res, Interdisciplinary Res Ctr, B-8500 Kortrijk, Belgium
[2] Univ Debrecen, Fac Med, Dept Clin Biochem & Mol Pathol, H-4012 Debrecen, Hungary
[3] Univ Utrecht, Med Ctr, Dept Haematol, Lab Thrombosis & Haemostasis, NL-3584 CX Utrecht, Netherlands
关键词
D O I
10.1074/jbc.M513314200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Soluble von Willebrand factor (VWF) has a low affinity for platelet glycoprotein (GP) Ib alpha and needs immobilization and/or high shear stress to enable binding of its A1 domain to the receptor. The previously described anti-VWF monoclonal antibody 1C1E7 enhances VWF/GPIb alpha binding and recognizes an epitope in the amino acids 764-1035 region in the N-terminal D'D3 domains. In this study we demonstrated that the D'D3 region negatively modulates the VWF/GPIb-IX-V interaction; (i) deletion of the D'D3 region in VWF augmented binding to GPIb alpha, suggesting an inhibitory role for this region, (ii) the isolated D'D3 region inhibited the GPIb alpha interaction of a VWF deletion mutant lacking this region, indicating that intramolecular interactions limit the accessibility of the A1 domain, (iii) using a panel of anti-VWF monoclonal antibodies, we next showed that the D'D3 region is in close proximity with the A1 domain in soluble VWF but not when VWF was immobilized; (iv) destroying the epitope of 1C1E7 resulted in a mutant VWF with an increased affinity for GPIb alpha. Our results support a model of domain translocation in VWF that allows interaction with GPIb alpha. The suggested shielding interaction of the A1 domain by the D'D3 region then becomes disrupted by VWF immobilization.
引用
收藏
页码:4699 / 4707
页数:9
相关论文
共 50 条
  • [1] Shielding the front A1 domain pocket of von Willebrand factor inhibits its binding to platelet glycoprotein Ibα.
    Bonnefoy, A
    Yamamoto, H
    Thys, C
    Kito, M
    Vermylen, J
    Hoylaerts, MF
    [J]. BLOOD, 2002, 100 (11) : 258A - 258A
  • [2] Shielding the front-strand β3 of the !von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibα
    Bonnefoy, A
    Yamamoto, H
    Thys, C
    Kito, M
    Vermylen, J
    Hoylaerts, MF
    [J]. BLOOD, 2003, 101 (04) : 1375 - 1383
  • [3] Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib
    Obert, B
    Houllier, A
    Meyer, D
    Girma, JP
    [J]. BLOOD, 1999, 93 (06) : 1959 - 1968
  • [4] Two anti-von Willebrand factor antibodies distinguish two regions of the A1 domain involved in binding to the platelet glycoprotein Ib-IX-V complex.
    Facey, DA
    Hertzberg, MS
    Koutts, J
    Favaloro, EJ
    Andrews, RA
    DeLuca, M
    Berndt, MC
    [J]. BLOOD, 1996, 88 (10) : 102 - 102
  • [5] Cytoskeletal regulation of the von Willebrand factor - Platelet glycoprotein Ib/V/IX interaction.
    Mistry, N
    Cranmer, SL
    Yuan, YP
    Giuliano, S
    Dopheide, SM
    Harper, IS
    Ulsemer, P
    Lanza, F
    Dunstan, D
    Jackson, SP
    [J]. BLOOD, 1999, 94 (10) : 441A - 441A
  • [6] Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von Willebrand factor interaction
    Mistry, N
    Cranmer, SL
    Yuan, YP
    Mangin, P
    Dopheide, SM
    Harper, I
    Giuliano, S
    Dunstan, DE
    Lanza, F
    Salem, HH
    Jackson, SP
    [J]. BLOOD, 2000, 96 (10) : 3480 - 3489
  • [7] The Von Willebrand Factor D'D3 Domains Modulate the Interacton of Platelet Receptor Glycoprotein Ib with the VWF-A1 Domain Under Conditions of Shear Stress
    Nowak, Agata Anna
    Shah, Amar
    Laffan, Michael
    McKinnon, Thomas A. J.
    [J]. BLOOD, 2011, 118 (21) : 963 - 963
  • [8] Modulation by heparin of the interaction of the A1 domain of von Willebrand factor with glycoprotein Ib
    Perrault, C
    Ajzenberg, N
    Legendre, P
    Rastegar-Lari, G
    Meyer, D
    Lopez, JA
    Baruch, D
    [J]. BLOOD, 1999, 94 (12) : 4186 - 4194
  • [9] Modulation by heparin of the interaction of the A1 domain of von Willebrand factor with glycoprotein Ib
    Ajzenberg, N
    Legendre, P
    Rastegar-Lari, G
    Meyer, D
    Lopez, JA
    Baruch, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 494 - 494
  • [10] Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ib alpha
    Miyata, S
    Goto, S
    Federici, AB
    Ware, J
    Ruggeri, ZM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) : 9046 - 9053